| Hans-Günter Meyer-Thompson | Hepatitiden
ILC 2017: European countries restrict access to life-saving treatment for hepatitis C
A review of recent reimbursement data showed considerable variability in access to direct-acting antiviral therapy based on amount of liver scarring and substance use. (European Association for the Study of the Liver, Press Release, 20.04.2017)
https://www.eurekalert.org/pub_releases/2017-04/eaft-i2e041217.php